NO961460L - Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider - Google Patents
Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptiderInfo
- Publication number
- NO961460L NO961460L NO961460A NO961460A NO961460L NO 961460 L NO961460 L NO 961460L NO 961460 A NO961460 A NO 961460A NO 961460 A NO961460 A NO 961460A NO 961460 L NO961460 L NO 961460L
- Authority
- NO
- Norway
- Prior art keywords
- aralkyl
- substituted
- aryl
- alkyl
- alkylcycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det er beskrevet azacykloalkylalkanoylpeptider og -pseudopeptider som hemmer blodplateaggregering og dannelse av tromber, og de er derfor anvendelige ved forebygging og behandling av trombose assosiert med sykdomstilstander som myokardialt infarkt, slag, perifer arteriell sykdom og disseminert intravaskulær koagulering, samt fremgangsmåter for å forebygge eller behandle trombose hos et pattedyr som er i behov av slik terapi, omfattende å tilføre en terapeutisk effek- tiv mengde av slike forbindelser, samt farmasøytiske blandinger omfattende slike forbindelser. Forbindelse av formel O il O n O II CH2V-C¿N-{CH2V-C-NH-CH-C-Z 'n i » *p i B CH2COOH hvori: A er -H, amidino eler substituert amidlno; B er alkyl, cykloalkyl, cykloalkylalkyl, alkylcyklo- alkyl, aryl, aralkyl, alkylaryl eller alkylaralkyl; Z er hvor E er -H eller, i kombinasjon med F, danner en 4-, 5-, 6- eller 7-leddet azacykloalkanring, F er or-karbon-sidekjeden av en naturlig forekommende a-ami- nosyre, -H-alkyl, cykloalkyl, cykloalkylalkyl, alkylcyklo- alkyl, alkylcykloalkylalkyl, aryl, substituert aryl, aral- kyl, substituert aralkyl, heterocyklyl, substituert hetero- cyklyl, heterocykloalkyl, substituert heterocyklylalkyl, eller, i kombinasjon med E, danner en 4-, S-, 6- eller 7- leddet azacykloalkanring. O er alkyl, cykloalkyl, cykloalkylalkyl, alkylcykloalkyl, alkylcykloalkylalky, aryl, substituert aryl, aralkyl, svibotituert aralkyl, heterocyklyl, substituert heterocyk- lyl, heterocyklylalkyl, substituert heterocyklylalkyl, OR1 eller NR1R', hvor R1 og R1 uavhengig av hverandre er -H, alkyl, cykloakyl, cykloalkylalkyl, alkylcykloalkyl, alkyl- cykloalkylalkyl, aryl, aralkyl, alkylaryl eller alkylaralk- yl, og r er O eller 1; R er H-, alkyl, aryl eller aralkyl; m er l til 5; n er O til 6; og p er l til 4; eller et farmasøytisk akseptabelt salt derav.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13882093A | 1993-10-15 | 1993-10-15 | |
| PCT/US1994/012135 WO1995010295A1 (en) | 1993-10-15 | 1994-10-17 | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961460D0 NO961460D0 (no) | 1996-04-12 |
| NO961460L true NO961460L (no) | 1996-06-17 |
Family
ID=22483811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961460A NO961460L (no) | 1993-10-15 | 1996-04-12 | Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5866685A (no) |
| EP (1) | EP0812205B1 (no) |
| JP (1) | JP3032297B2 (no) |
| KR (1) | KR100304332B1 (no) |
| CN (1) | CN1135717A (no) |
| AT (1) | ATE199727T1 (no) |
| AU (1) | AU703854B2 (no) |
| BG (1) | BG63166B1 (no) |
| BR (1) | BR9407839A (no) |
| CA (1) | CA2174097C (no) |
| CZ (1) | CZ291378B6 (no) |
| DE (1) | DE69426897T2 (no) |
| DK (1) | DK0812205T3 (no) |
| ES (1) | ES2155122T3 (no) |
| FI (1) | FI961634A7 (no) |
| GR (1) | GR3035581T3 (no) |
| HU (1) | HU222248B1 (no) |
| NO (1) | NO961460L (no) |
| NZ (1) | NZ275948A (no) |
| PL (1) | PL181749B1 (no) |
| PT (1) | PT812205E (no) |
| RO (1) | RO115520B1 (no) |
| RU (1) | RU2134695C1 (no) |
| SG (1) | SG64919A1 (no) |
| SK (1) | SK47796A3 (no) |
| UA (1) | UA44258C2 (no) |
| WO (1) | WO1995010295A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| US6274705B1 (en) | 1996-05-02 | 2001-08-14 | Aventis Pharmaceuticals Products Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| UA44258C2 (uk) * | 1993-10-15 | 2002-02-15 | Рон-Пуленк Рорер Фармасьютікалз Інк. | Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти) |
| PL331772A1 (en) | 1996-08-21 | 1999-08-02 | Rhone Poulenc Rorer Pharma | Stable non-hygroscopic crystalline form of n-[n-n-(4-piperidin-4-yl)-n-ethylglycin] compounds |
| AU754936B2 (en) * | 1996-11-27 | 2002-11-28 | Aventis Pharmaceuticals Inc. | Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound |
| WO1999019294A1 (en) * | 1997-05-14 | 1999-04-22 | Aventis Pharmaceuticals Products Inc. Legal/Patents | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| EA002724B1 (ru) * | 1997-10-10 | 2002-08-29 | Авентис Фармасьютикалз Продактс Инк. | Способ получения азациклоалкилалканоилпсевдотетрапептидов |
| WO2000040601A1 (en) * | 1998-12-30 | 2000-07-13 | Aventis Pharmaceuticals Products Inc. | Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide |
| RU2250212C2 (ru) * | 2000-01-28 | 2005-04-20 | Авентис Фарма Дойчланд Гмбх | Способ получения ацетиламидиниофенилаланилциклогексилглицилпиридиниоаланинамидов |
| PL205134B1 (pl) * | 2000-03-27 | 2010-03-31 | Scripps Research Inst | Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny |
| CN101735307B (zh) * | 2008-11-18 | 2012-05-30 | 北京航空航天大学 | 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用 |
| CA2876177C (en) * | 2012-06-11 | 2022-06-14 | The Cleveland Clinic Foundation | Treatment and prevention of cardiovascular disease and thrombosis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
| FR2608160B1 (fr) * | 1986-12-15 | 1989-03-31 | Inst Nat Sante Rech Med | Nouveaux derives peptidiques et leur application notamment en therapeutique |
| US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
| US4992463A (en) * | 1988-07-20 | 1991-02-12 | Monsanto Company | Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation |
| US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
| US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
| CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
| US5023233A (en) * | 1989-07-28 | 1991-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| CA2066047A1 (en) * | 1989-09-29 | 1991-03-30 | Scott I. Klein | Anti-thrombotic peptides and pseudopeptides |
| US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
| US5064814A (en) | 1990-04-05 | 1991-11-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| IL99539A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
| EP0503203A1 (en) * | 1991-03-15 | 1992-09-16 | Merrell Dow Pharmaceuticals Inc. | Novel thrombin inhibitors |
| JPH08503920A (ja) * | 1991-04-11 | 1996-04-30 | ローヌ−プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド | 抗血栓ペプチドおよび偽ペプチド誘導体 |
| SE9102462D0 (sv) * | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
| UA44258C2 (uk) * | 1993-10-15 | 2002-02-15 | Рон-Пуленк Рорер Фармасьютікалз Інк. | Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти) |
-
1994
- 1994-10-17 UA UA96051845A patent/UA44258C2/uk unknown
- 1994-10-17 PL PL94313975A patent/PL181749B1/pl unknown
- 1994-10-17 ES ES95900403T patent/ES2155122T3/es not_active Expired - Lifetime
- 1994-10-17 RU RU96109375/04A patent/RU2134695C1/ru not_active IP Right Cessation
- 1994-10-17 JP JP7512250A patent/JP3032297B2/ja not_active Expired - Fee Related
- 1994-10-17 HU HU9600983A patent/HU222248B1/hu not_active IP Right Cessation
- 1994-10-17 PT PT95900403T patent/PT812205E/pt unknown
- 1994-10-17 SG SG1996008589A patent/SG64919A1/en unknown
- 1994-10-17 DE DE69426897T patent/DE69426897T2/de not_active Expired - Lifetime
- 1994-10-17 WO PCT/US1994/012135 patent/WO1995010295A1/en not_active Ceased
- 1994-10-17 SK SK477-96A patent/SK47796A3/sk unknown
- 1994-10-17 FI FI961634A patent/FI961634A7/fi unknown
- 1994-10-17 EP EP95900403A patent/EP0812205B1/en not_active Expired - Lifetime
- 1994-10-17 AU AU81237/94A patent/AU703854B2/en not_active Ceased
- 1994-10-17 AT AT95900403T patent/ATE199727T1/de not_active IP Right Cessation
- 1994-10-17 CA CA002174097A patent/CA2174097C/en not_active Expired - Fee Related
- 1994-10-17 CZ CZ19961084A patent/CZ291378B6/cs not_active IP Right Cessation
- 1994-10-17 KR KR1019960701992A patent/KR100304332B1/ko not_active Expired - Fee Related
- 1994-10-17 RO RO96-00812A patent/RO115520B1/ro unknown
- 1994-10-17 NZ NZ275948A patent/NZ275948A/en unknown
- 1994-10-17 BR BR9407839A patent/BR9407839A/pt not_active Application Discontinuation
- 1994-10-17 DK DK95900403T patent/DK0812205T3/da active
- 1994-10-17 US US08/628,648 patent/US5866685A/en not_active Expired - Lifetime
- 1994-10-17 CN CN94194242A patent/CN1135717A/zh active Pending
-
1996
- 1996-04-12 NO NO961460A patent/NO961460L/no not_active Application Discontinuation
- 1996-04-26 BG BG100544A patent/BG63166B1/bg unknown
-
2001
- 2001-03-15 GR GR20010400194T patent/GR3035581T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2170232C2 (ru) | Амиды фосфиновых кислот и способ предупреждения или лечения заболевания, связанного с нежелательной активностью металлопротеазы | |
| NO961460L (no) | Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider | |
| ES2379948T3 (es) | Composición medicinal que comprende Tacrine o Donepezil para mejorar la función cerebral | |
| IL112222A (en) | Pharmaceutical compositions containing n-substituted azaheterocyclic carboxylic acids and esters thereof certain such compounds and their preparation | |
| ES2040242T3 (es) | Composiciones farmaceuticas. | |
| EP0512831A1 (en) | Fibrinogen receptor antagonists | |
| KR20000035918A (ko) | 1,3-디헤테로시클릭 메탈로프로테아제 저해제 | |
| MX9707531A (es) | Nuevos compuestos heterociclicos. | |
| MXPA04000338A (es) | Diamindioles para tratamiento de enfermedad de alzheimer. | |
| KR20010042694A (ko) | 치환 피롤리딘 히드록사메이트 메탈로프로테아제 억제제 | |
| US5190937A (en) | Lactam derivatives | |
| MXPA03011521A (es) | Aminadioles para tratamiento de enfermedad de alzheimer. | |
| RU94036771A (ru) | Ингибиторы ангиогенеза и ангиогенных заболеваний | |
| DE69125216D1 (de) | Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen | |
| IL93989A0 (en) | Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases | |
| AU5100296A (en) | Novel heterocyclic compounds | |
| EP0322633B1 (en) | Mercapto-acylamino acid antihypertensives | |
| MXPA04000337A (es) | Amindioles para tratamiento de enfermedad de alzheimer. | |
| BG100246A (en) | N-substituted azaheterocylic carboxylic acids and their esters | |
| ZA891769B (en) | Heterocyclic compounds | |
| EP0612324A1 (en) | Phosphonopeptides with collagenase inhibiting activity | |
| BR0214293A (pt) | Composto e métodos para tratar um paciente que tenha, ou de prevenir um paciente de adquirir, uma doença ou condição e para produzir um composto ou um sal ou éster farmaceuticamente aceitável do mesmo | |
| US5932551A (en) | Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents | |
| IL117811A0 (en) | N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them | |
| WO2000043007A1 (en) | Troglitazone-containing medicinal compositions for inhibiting apoptosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |